• Skip to main content
  • Skip to footer

Oklahoma Medical Research Foundation (OMRF)

Discoveries that make a difference.

  • About
    • General Information
    • Disease Research
    • Education & Outreach
    • Events
    • Jobs
    • Contact Us
  • Science
    • Scientist Directory
    • Research Programs
    • Research Centers
    • Core Facilities
    • Scientific Publications
    • Scientific Seminars
    • Technology Ventures
  • News
    • Media Resources
    • OMRF in the Media
    • OMRF News
    • OMRF Publications
    • OMRF Videos
  • Patients
    • Lupus (SLE)
    • Multiple Sclerosis
    • Rheumatoid Arthritis
    • Sarcoidosis
    • Sjögren’s Syndrome
    • Other Autoimmune Disorders
  • Donate
    • Donate Now
    • Donor Events
    • Tax Credit
    • Gift Planning
    • Why We Give
    • Your Gift at Work
    • Donor Recognition
    • Contact
Home - OMRF News - Archives for Towner

Towner

OMRF discovers compound that could fight deadly cancer

January 21, 2019

Glioblastoma is an aggressive form of brain cancer with no cure, but a new OMRF discovery offers hope.

Filed Under: News Tagged With: biomedical, brain, brain cancer, cancer, compound, cure, developed, drug, eltd1, glioblastoma, john mccain, medicine, news, newsok, nonprofit, OKC, Oklahoma City, Oklahoma Medical Research Foundation, OMRF, pharma, Rheal, rheal towner, scientist-news, ted kennedy, Towner, treat, treatment

Oblato acquires all rights to glioblastoma drug from OMRF

October 29, 2018

Oblato, Inc., has acquired all rights from OMRF to OKN-007, an investigational drug for the treatment of a deadly form of brain cancer.

Filed Under: News, Technology Ventures News Tagged With: 007, americans, brain, cancer, clinical, deadly, diagnosis, drug, edward kennedy, Gtree, james battiste, john mccain, Manu Nair, mike schuster, model, news, Norman, Oblato, Oklahoma Medical Research Foundation, okn, OKN-007, OMRF, Rheal, rheal towner, robert floyd, scientist-news, Stephenson Cancer Center, technology, testing, therapy, Towner, treatment, trial, tumor, university of oklahoma

Staying alive: Can an experimental OMRF drug stop Mike Schuster’s brain cancer?

September 11, 2018

As Mike Schuster nears the three-year anniversary of his diagnosis with glioblastoma, he’s already doubled the life expectancy for patients with the deadly cancer.

Filed Under: News, Technology Ventures News Tagged With: aggressive, battiste, brain, brain cancer, cancer, deadly, death, develop, disease, drug, glioblastoma, john mccain, life expectancy, live, longer, mike schuster, MRI, newsok, Norman, OKC, Oklahoma City, Oklahoma Medical Research Foundation, OKN-007, OMRF, OUHSC, patients, Rheal, scientist-news, Stephenson Cancer Center, Towner, tumor

OMRF hosts 2018 Loyal Donors reception

May 15, 2018

OMRF officials brought more than 110 long-time donors together from across the state to celebrate their dedicated supporters at the annual Loyal Donor Society reception.

Filed Under: News Tagged With: cancer, Courtney, Deshmukh, development, disease, donations, donor, facility, foundation, giving, institute, Kinter, loyal, Michael, Montgomery, newsok, officials, OKC, Oklahoma City, Oklahoma Medical Research Foundation, OMRF, philanthropy, research, Rheal, science, scientist-news, support, Towner, Umesh, Wan, Yoon

Q BioMed Inc. finalizes license agreement with OMRF, RGCB

June 15, 2017

QBioMed has the global exclusive rights to develop and market a novel chemotherapeutic drug to treat liver cancer.

Filed Under: News, Technology Ventures News Tagged With: agreement, cancer, cells, chemo, denis corin, develop, drug, license, liver cancer, medical, OKC, Oklahoma City, Oklahoma Medical Research Foundation, OMRF, otcqb, q biomed, qbio, rajiv gandhi centre for biotechnology, research, rgcb, Rheal, rheal towner, rights, scientist-news, therapy, Towner, uttrocide b

Investigating the role of obesity in arthritis

February 21, 2017

Osteoarthritis, or OA, is the most common form of disability in the U.S.

Filed Under: News Tagged With: arthritis, degeneration, disease, erika barboza pardo lopes, fat pad, Florea, formation, Griffin, knee, knee joint, Kovats, lab, Lupu, oa, obesity, OKC, Oklahoma City, Oklahoma Medical Research Foundation, OMRF, onset, osteoarthritis, overweight, pain, Rheal, scientist-news, Susan, Tim Griffin, Timothy, timothy griffin, Towner

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 6
  • Go to Next Page »

Before Footer

EEO/AA Employer/Vet/Disabled

Footer

  • Jobs
  • Directory
  • Donor Privacy Statement
  • Intranet
Charity navigator
United Way Give Smart OKC
Facebook Twitter YouTube Instagram Mail Linkedin
Administrator Log In